2021 - 24th Pharmacovigilance 2021 (Virtual Conference)

FOCUSES ON
Overcoming this Pandemic Issues - Drug Safety Strategy for Pharmaceutical organisations
Outsourcing in Pharmacovigilance- Best Practices, Challenges and key consideration
Key factors driving the current global Pharmacovigilance (PV) market?
Pharmacovigilance and assessment of drug safety reports during COVID 19
What are the market opportunities, market risk and market overview of the (PV) market?
PV Audit & Inspections – Keeping on the right side of Inspectors
Documentation (RMPs, PSURs, PADERs, PBRERs)
Practical approaches - Quality, Safety & Signal Detection
Medical devices – Increasing safety perspective
Improving patient safety
New Technologies in Pharmacovigilance (AI/ Machine Learning, IoT)
Brexit Implications for the Pharmaceutical (pharmacovigilance) Industry
RoW - Recent developments and future perspectives
The developing regulatory framework in advanced and developing markets – EU, USA & ROW
Be part of a major networking opportunity